Skip to main content
. 2024 Jan 21;7(1):e1743. doi: 10.1002/hsr2.1743

Table 3.

Tolerance evaluated by subjects 3 months after the end of the treatment (T2).

Tolerance % Of subjects
Excellent 68
Good 24
Medium 8
Poor 0
Bad 0